Reirradiation: A potentially curative approach to locally or regionally recurrent head and neck cancer

Current Opinion in Oncology

Volumn 14, Issue 3, 2002, Pages 330-333

  Garofalo, Michael C ^a   Haraf, Daniel J ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; FLUOROURACIL; HYDROXYUREA; MITOMYCIN C; PACLITAXEL;

CANCER CHEMOTHERAPY; CANCER PALLIATIVE THERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; HEAD AND NECK CANCER; HUMAN; PRIORITY JOURNAL; REVIEW; SURGICAL APPROACH; TREATMENT PLANNING;

ANTINEOPLASTIC AGENTS; CLINICAL TRIALS; COMBINED MODALITY THERAPY; HEAD AND NECK NEOPLASMS; HUMANS; NEOPLASM RECURRENCE, LOCAL; RADIATION DOSAGE; SALVAGE THERAPY;

EID: 0036250150     PISSN: 10408746     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001622-200205000-00013     Document Type: Review

References (35)

1. Cancer of the head and neck
2. Metastatic patterns in squamous cell carcinoma of the head and neck
3. Analysis of distant metastases in squamous cell carcinoma of the head and neck and lesions above the clavicle at autopsy
4. Patterns of relapse in locally advanced head and neck cancer patients who achieved a complete remission after combined modality treatment
5. Squamous cancer of the head and neck: Surgical treatment of local and regional recurrence
6. Recurrent head and neck cancer: The results of treatment
7. Chemotherapy in head and neck cancer: Current concepts
8. Treatment of carcinoma of the head and neck with intravenous methotrexate
9. 24 Hour infusion of cisplatinum in head and neck cancer
10. Head and neck cancer
11. Randomized comparison of cisplatin plus fluorouracil and carboplatin plus fluorouracil versus methotrexate in advanced squamous cell carcinoma of the head and neck: A Southwest Oncology Group study
12. A phase III randomized trial of cis-platinum, methotrexate, cisplatinum + methotrexate and cisplatinum + 5-FU in end stage squamous carcinoma of the head and neck
13. A phase III randomized study comparing cisplatin and fluorouracil as single agents and in combination for advanced squamous cell carcinoma of the head and neck
14. A randomized phase III study of cisplatin with or without methotrexate for recurrent squamous cell carcinoma of the head and neck: A Northern California Oncology Group study
15. A randomized prospective comparison of methotrexate with a combination of methotrexate, bleomycin and cisplatin in head and neck cancer
16. Chemotherapy for head and neck cancer: Comparison of cisplatin + vinblastine + bleomycin versus methotrexate
17. Radioresistant tumor cells are present in head and neck carcinomas that recur after radiotherapy
18. Early and late radiation changes following a second course of irradiation
19. Long-term recovery of connective tissue after irradiation
20. Hyperfractionation in the reirradiation of head and neck cancers: Results of a pilot study
21. Induction chemotherapy plus irradiation compared with surgery plus irradiation in patients with advanced laryngeal cancer
22. Larynx preservation in pyriform sinus cancer: Preliminary results of a European Organization for Research and Treatment of Cancer phase III trial
23. Treatment of advanced squamous-cell carcinoma of the head and neck with alternating chemotherapy and radiotherapy
24. Five-year update of a randomized trial of alternating radiotherapy and chemotherapy compared with radiotherapy alone in treatment of unresectable squamous cell carcinoma of the head and neck
25. Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer
26. Reirradiation of recurrent tumors in the head and neck
27. Reirradiation of recurrent head and neck cancers
28. High-dose reirradiation of head and neck cancer with curative intent
29. Re-irradiation with concomitant chemotherapy of unresectable recurrent head and neck cancer: A potentially curable disease
30. Full-dose reirradiation for unresectable head and neck carcinoma: Experience at the Gustave-Roussy Institute in a series of 169 patients
31. Recurrent head and neck cancer: Retreatment of previously irradiated areas with combined chemotherapy and radiation therapy: Result of a prospective study
32. Conformal re-irradiation of recurrent and new primary head-and-neck cancer
33. Full dose reirradiation combined with chemotherapy after salvage surgery in head and neck cancer
34. Phase I study of concomitant chemoradiotherapy with paclitaxel, fluorouracil, and hydroxyurea with granulocyte colony-stimulating factor support for patients with poor-prognosis cancer of the head and neck
35. High dose re-irradiation with concomitant chemotherapy for local/regionally recurrent head and neck cancer (NHC): Results in 48 patients